Conventional cancer treatment often overlooks the uniqueness of each person’s cancer, treating all cases as one homogeneous pool. But every cancer patient deserves more than a one-size-fits-all approach.

Our cancer-based research and testing works at the forefront of innovation to devise new testing protocols that are personalized for each patient’s cancer biology. 

At RGCC, we believe in personalized treatment that considers the individuality of each patient and the unique expression of the cancer cells within each patient’s unique genetic makeup and physiology.

With our comprehensive suite of testing panels, RGCC partners with patients and practitioners throughout the cancer journey. These powerful testing tools provide actionable information about what is driving the progression of the patient’s cancer, allowing for the creation of personalized treatment protocols tailored to each patient as an individual, providing the potential for better outcomes.